Clinical trial NCT01389245: Study on OsseoSpeed™ TX Implants in the Upper Jaw in a Chinese Population
Official title: An Open, Prospective, Multi-center Study to Evaluate the OsseoSpeed™ TX Implant With an Early Loading Protocol in Patients With Tooth Loss in the Posterior Maxilla. A 3-years Follow-up Study.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Partially Edentulous Jaw
Lead sponsor: Dentsply Sirona Implants and Consumables
Sponsor class: INDUSTRY
First posted: 2011-07-08
Enrollment: 42
Sex: ALL
Minimum age (years): 20
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the posterior maxilla is a safe and predictable procedure.


Eligibility criteria: Inclusion criteria:

1. Provision of informed consent
2. Aged 20-75 years at enrollment
3. History of edentulism in the posterior maxilla, Kennedy classes I or II, of at least four months. Last natural tooth in function is canine or first bicuspid.
4. Neighboring tooth to the planned bridge must have natural root.
5. Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned bridge.
6. Deemed by the investigator to have adequate bone height and a bone width of minimum 5.5 mm.
7. Deemed by the investigator as likely to present an initially stable implant situation

Exclusion criteria:

1. Unlikely to be able to comply with study procedures, as judged by the investigator
2. Earlier graft procedures in the study area
3. Current need for pre-surgical bone or soft tissue augmentation in the planned implant area.
4. Uncontrolled pathologic processes in the oral cavity
5. Known or suspected current malignancy
6. History of radiation therapy in the head and neck region
7. History of chemotherapy within 5 years prior to surgery
8. Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration
9. Uncontrolled diabetes mellitus
10. Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration
11. Smoking more than 10 cigarettes/day
12. Present alcohol and/or drug abuse
13. Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
14. Previous enrollment in the present study.
15. Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months.
16. Subjects that are unable to give informed consent

Primary outcomes:
measure: Marginal Bone Level Alteration
timeFrame: Measured at implant loading and at the 3-year follow-up after implant loading.
Secondary outcomes:
measure: Number of Stable Implants
timeFrame: Measured at the 3-year follow-up after implant loading.
measure: Evaluation of the Periimplant Mucosa Condition - By Assessment of PPD
timeFrame: Measured at the 3-year follow-up after implant loading.
measure: Number of Survived Implants
timeFrame: Measured at the 3-year follow-up after implant loading.
measure: Presence of Plaque
timeFrame: Measured at the 3-year follow-up after implant loading.
Other outcomes:
Locations:
city: Beijing
country: China
facility: Capital Medical University School of Stomatology, Centre of Oral Implantation
city: Guangzhou
country: China
facility: Guanghua School of Stomatology, Sun Yat-Sen University
city: Nanjing
country: China
facility: Department of Prosthodontics, Nanjing Stomatology Hospital, Nanjing University
Study officials:
affiliation: Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou
name: Deng Feilong, MD
role: PRINCIPAL_INVESTIGATOR
References: